These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 19912057)
21. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes. Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507 [TBL] [Abstract][Full Text] [Related]
22. An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors. Weng H; Li J; Zhu H; Carver Wong KF; Zhu Z; Xu J Future Med Chem; 2023 Jan; 15(1):73-95. PubMed ID: 36756851 [TBL] [Abstract][Full Text] [Related]
23. Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site. Lin S; Du T; Zhang J; Wu D; Tian H; Zhang K; Jiang L; Lu D; Sheng L; Li Y; Ji M; Chen X; Xu H J Med Chem; 2022 Dec; 65(24):16372-16391. PubMed ID: 36511661 [TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker. Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940 [TBL] [Abstract][Full Text] [Related]
25. A comprehensive assessment of a new series of 5',6'-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs). Riu F; Sanna L; Ibba R; Piras S; Bordoni V; Scorciapino MA; Lai M; Sestito S; Bagella L; Carta A Eur J Med Chem; 2021 Oct; 222():113590. PubMed ID: 34139625 [TBL] [Abstract][Full Text] [Related]
26. New indole-based chalconoids as tubulin-targeting antiproliferative agents. Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629 [TBL] [Abstract][Full Text] [Related]
27. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents. Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147 [TBL] [Abstract][Full Text] [Related]
29. Combined Molecular Docking, 3D-QSAR, and Pharmacophore Model: Design of Novel Tubulin Polymerization Inhibitors by Binding to Colchicine-binding Site. Li DD; Qin YJ; Zhang X; Yin Y; Zhu HL; Zhao LG Chem Biol Drug Des; 2015 Oct; 86(4):731-45. PubMed ID: 25711282 [TBL] [Abstract][Full Text] [Related]
30. [Progress in the study of tubulin inhibitors]. Shang H; Pan L; Yang S; Chen H; Cheng MS Yao Xue Xue Bao; 2010 Sep; 45(9):1078-88. PubMed ID: 21351562 [TBL] [Abstract][Full Text] [Related]
31. Identification of Essential 2D and 3D Chemical Features for Discovery of the Novel Tubulin Polymerization Inhibitors. Azimi F; Ghasemi JB; Saghaei L; Hassanzadeh F; Mahdavi M; Sadeghi-Aliabadi H; Scotti MT; Scotti L Curr Top Med Chem; 2019; 19(13):1092-1120. PubMed ID: 31109275 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents. Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446 [TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site. Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319 [TBL] [Abstract][Full Text] [Related]
35. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo. Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors. Xu S; An B; Li Y; Luo X; Li X; Jia X Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981 [TBL] [Abstract][Full Text] [Related]
37. Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin. Tyagi C; Gupta A; Goyal S; Dhanjal J; Grover A BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S3. PubMed ID: 25521775 [TBL] [Abstract][Full Text] [Related]
38. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells. Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540 [TBL] [Abstract][Full Text] [Related]
39. New indolesulfonamide derivatives targeting the colchicine site of tubulin: synthesis, anti-tumour activity, structure-activity relationships, and molecular modelling. Vicente-Blázquez A; González M; Medarde M; Mollinedo F; Peláez R J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2025-2044. PubMed ID: 34514909 [TBL] [Abstract][Full Text] [Related]
40. Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues. do Amaral DN; Cavalcanti BC; Bezerra DP; Ferreira PM; Castro Rde P; Sabino JR; Machado CM; Chammas R; Pessoa C; Sant'Anna CM; Barreiro EJ; Lima LM PLoS One; 2014; 9(3):e85380. PubMed ID: 24614859 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]